Mainz (dpa/lrs) - Microsoft-Gründer Bill Gates hat den Mainzer Impfstoffhersteller Biontech besucht. Er traf bei dem Besuch ...

Türeci forscht zu Krebstherapien Biontech-Gründerin wird Professorin in Mainz 08.12.2021, 06:58 Uhr Mit der Universität Mainz ist Türeci seit Jahrzehnten verbunden - sie hat dort habilitiert.

We rate BioNTech SE a hold due to volatile performance, weak growth, and premium valuation amidst COVID-19 vaccine reliance.

The headline news in the new agreement is the formation of a joint AI Innovation Lab – split between InstaDeep’s headquarters in London in the UK and BioNTech’s site in Mainz Germany ...

Durften Biontech und Pfizer die mRNA-Technologie der US-Konkurrenz auf Dauer lizenzfrei nutzen? Moderna überzieht das Mainzer ...

More about BioNTech SE BioNTech SE is a biotechnology company based in Mainz, Germany, primarily known for its development of mRNA-based vaccines and immunotherapies. The company is a significant ...

BioNTech SE operates as immunotherapy company ... 2008 and is headquartered in Mainz, Germany.

BioNTech SE operates as immunotherapy company ... 2008 and is headquartered in Mainz, Germany.

Executing in oncology with investigational BNT327/PM8002 combinations and mRNA cancer immunotherapy candidates as pan-tumor treatment approachesBioNTech aims to develop BNT327/PM8002 as a next-generat ...

Microsoft-Gründer Bill Gates hat den Mainzer Impfstoffhersteller Biontech besucht. Er traf bei dem Besuch am vergangenen Montag unter anderem die beiden Biontech-Mitbegründer Ugur Sahin und ...

https://www.tipranks.com/news/the-fly/si-bone-price-target-raised-to-20-from-19-at-needham BioNTech SE ( (BNTX) ) has provided an update. BioNTech SE has settled a ...